Publications by authors named "Yuko Mitobe"

Claim this Profile
E
Effect of food on iron absorption in patients with iron deficiency anemia treated with ferric citrate hydrate.
Norio Komatsu, Kyoko Ito, Kojo Arita, Yuko Mitobe, Hironori Mitsui

Int J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between serum hepcidin-25 levels and hyporesponsiveness to erythropoiesis-stimulating agents in Japanese patients receiving hemodialysis: a cross-sectional study.
Ryo Fujikawa, Nobuo Nagano, Yuko Mitobe, Kyoko Ito

Clin Exp Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter Single-Arm Study of Switching to Ferric Citrate Hydrate for Iron Deficiency Anemia in Patients Intolerant to Oral Iron: RIO-SWITCH.
Osamu Wada-Hiraike, Aya Maruyama, Yuko Mitobe, Takayuki Iriyama, Mayuyo Mori-Uchino

Adv Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia.
Mikio Momoeda, Kyoko Ito, Sachie Inoue, Hidetoshi Shibahara, Yuko Mitobe

Int J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Upper Gastrointestinal Motility in Mice Treated with Oral Iron Tablets.
Syunki Yamada, Taiki Mihara, Tamaki Kurosawa, Aya Maruyama, Katsuyo Ohashi-Doi, Yuko Mitobe

Biol Pharm Bull· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Ferric citrate hydrate improves transferrin saturation in patients with low levels of transferrin saturation undergoing hemodialysis.
Keitaro Yokoyama, Ryo Inoue, Kyoko Ito, Yuko Mitobe

Ren Fail· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia.
Kyoko Ito, Tadao Akizawa, Kojo Arita, Yuko Mitobe, Norio Komatsu

Clin Exp Nephrol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The quality of life and work productivity are affected by the presence of nausea/vomiting in patients taking iron preparations for heavy menstrual bleeding or anemia: a population-based cross-sectional survey in Japan.
Kyoko Ito, Yuko Mitobe, Ryo Inoue, Mikio Momoeda

BMC Womens Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Impact of nausea/vomiting on EQ-5D-5L utility scores in patients taking iron preparations for heavy menstrual bleeding or anemia.
Kyoko Ito, Yuko Mitobe, Ryo Inoue, Mikio Momoeda

BMC Womens Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of nausea/vomiting on EQ-5D-5L utility scores in patients taking iron preparations for heavy menstrual bleeding or anemia.
Kyoko Ito, Yuko Mitobe, Ryo Inoue, Mikio Momoeda

BMC Womens Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Japanese Cedar Pollen Allergens in Japan.
Katsuyo Ohashi-Doi, Daichi Utsumi, Yuko Mitobe, Koji Fujinami

Curr Protein Pept Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
Katsuyo Ohashi-Doi, Kaare Lund, Yuko Mitobe, Kazuhiro Okamiya

Biol Pharm Bull· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[DIFFERENCE BETWEEN STANDARDIZED MITE ANTIGEN AND HOUSE DUST EXTRACT IN RUSH SUBCUTANEOUS IMMUNOTHERAPY FOR CHILDREN].
Yuya Tanaka, Ikuo Okafuji, Saori Omae, Yuko Mitobe, Kastuyo Doi

Arerugi· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicologic Pathology Forum: Current Status on the Use of Animal Models of Human Disease in the Pharmaceutical Industry in Japan in Nonclinical Safety Assessment-Opinion Paper.
Masayuki Tomohiro, Takeshi Okabe, Yasushi Kimura, Kiyoshi Kinoshita, Mitsunori Maeda, Yuko Mitobe

Toxicol Pathol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Yuko Mitobe, Yasuki Yokomoto, Katsuyo Ohashi-Doi

Regul Toxicol Pharmacol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist.
Yuji Haga, Toshihiro Sakamoto, Takunobu Shibata, Katsumasa Nonoshita, Makoto Ishikawa, Yuko Mitobe

Bioorg Med Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of positron emission tomography ligands for NPY Y5 receptors in the brain.
Hirobumi Takahashi, Yuji Haga, Takunobu Shibata, Katsumasa Nonoshita, Toshihiro Sakamoto, Yuko Mitobe

Bioorg Med Chem Lett· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, structure-activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H(3) receptor inverse agonists.
Takahide Sasaki, Toshiyuki Takahashi, Tsuyoshi Nagase, Takashi Mizutani, Sayaka Ito, Yuko Mitobe

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
Yuko Mitobe, Sayaka Ito, Takashi Mizutani, Tsuyoshi Nagase, Nagaaki Sato

Bioorg Med Chem Lett· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor.
Makoto Ando, Nagaaki Sato, Tsuyoshi Nagase, Keita Nagai, Shiho Ishikawa, Yuko Mitobe

Bioorg Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Ryuichi Moriya, Satoshi Mashiko, Akane Ishihara, Toshiyuki Takahashi, Takashi Murai, Yuko Mitobe

Peptides· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.
Tsuyoshi Nagase, Takashi Mizutani, Etsuko Sekino, Shiho Ishikawa, Sayaka Ito, Yuko Mitobe

J Med Chem· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
Yoshio Ogino, Norikazu Ohtake, Yoshikazu Nagae, Kenji Matsuda, Minoru Moriya, Yuko Mitobe

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
Yoshio Ogino, Norikazu Ohtake, Yoshikazu Nagae, Kenji Matsuda, Makoto Ishikawa, Yuko Mitobe

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists.
Tsuyoshi Nagase, Takashi Mizutani, Shiho Ishikawa, Etsuko Sekino, Takahide Sasaki, Yuko Mitobe

J Med Chem· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis